LandBridge Company LLC (LB) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 20.14%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 20.14% | Share-based compensation / revenue. Period ending 2026-06-30. $45.41M ÷ $225.45M × 100 ≈ 20.14% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 225.45M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 45.41M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 138.30M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $225.45M | $45.41M | $138.30M | (m) | (m) | 20.14% | (m) | (m) |
| 2026-03-31 | (m) | $206.15M | $45.44M | $122.64M | (m) | (m) | 22.04% | (m) | (m) |
| 2025-12-31 | (m) | $199.09M | $45.32M | $118.50M | (m) | (m) | 22.76% | (m) | (m) |
| 2025-09-30 | (m) | $178.81M | $44.77M | $102.44M | (m) | (m) | 25.04% | (m) | (m) |
| 2025-06-30 | (m) | $156.47M | $45.17M | $74.75M | (m) | (m) | 28.87% | (m) | (m) |
| 2025-03-31 | (m) | $134.89M | $105.67M | $-4.99M | (m) | (m) | 78.33% | (m) | (m) |
| 2024-12-31 | (m) | $109.95M | $95.33M | $-16.51M | (m) | (m) | 86.70% | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $72.86M | $-17.23M | $70.01M | (m) | (m) | -23.65% | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.